4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow Manic Episode: new trials by email Literature Review of Manic Episode trials Research Report on Manic Episode
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder Brexpiprazole, Placebo - Bipolar I Disorder, Manic Episode | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 333 | 2017-09-19 | 2020-02-11 |
| A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder Brexpiprazole, Placebo - Bipolar I Disorder, Manic Episode | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 322 | 2017-09-14 | 2020-02-10 |
| A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder Risperidone, oral tablets - Bipolar Disorder, Manic Episode | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 291 | 2001-03-01 | 2011-01-14 |
| A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder Risperidone, oral tablets - Bipolar Disorders, Manic Episode | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 267 | 2000-12-01 | 2011-01-14 |
Mania (4) · Bipolar Disorder (2)
Nervous System Diseases (4) · Neurobehavioral Manifestations (4) · Neurologic Manifestations (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Bipolar and Related Disorders (2) · Mental Disorders (2) · Mood Disorders (2)
Risperidone (2) · brexpiprazole (2)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · Otsuka Pharmaceutical Development & Commercialization, Inc. (2)
United States (2) · Bulgaria (1) · Croatia (1) · Poland (1) · Serbia (1) · Ukraine (1)